Eric I. Richman - 16 Aug 2021 Form 4/A - Amendment Insider Report for Gain Therapeutics, Inc. (GANX)

Role: Chief Executive Officer, Director
Signature: /s/ Trevor Bossi, Attorney-in-Fact
Issuer symbol: GANX
Transactions as of: 16 Aug 2021
Net transactions value: +$38,716
Form type: 4/A - Amendment
Filing time: 21 Apr 2022, 16:50:22 UTC
Date Of Original Report: 17 Aug 2021
Previous filing: 21 Apr 2022
Next filing: 17 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GANX	Common Stock	Purchase	$38,716	+4,922	+2.3%	$7.87	216,820	16 Aug 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The original Form 4 filed on August 17, 2021 incorrectly listed the transaction code at "M" instead of "P".

Remarks:

On the original Form 4 filed on August 17, 2021, the Reporting Person's relationship the the Issuer omitted listing him as the Chief Executive Officer.